Advanced Filters
noise

Osteoporosis Clinical Trials

A listing of Osteoporosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 116 clinical trials
A Ayça Utkan Karasu, M.D.

Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis

Postmenopausal osteoporosis is characterized by low bone mass and increased fracture risk. Treatment includes exercise, nutrition, supplements, and medications like bisphosphonates, denosumab, or hormone replacement therapy. Lifestyle changes such as quitting smoking, reducing alcohol consumption, and preventing falls are also crucial. Despite effective treatments, adherence is low: 20-30% of patients …

45 years of age Female Phase N/A
N Nur ALP, MSc,Lecturer

Contribution of Recreational Exercises to Balance and Muscle Strength in Osteoporosis Risk

This study aims to evaluate the effects of recreational exercises such as Pilates, swimming and walking on muscle strength and balance in women at risk of osteoporosis. Study hypotheses: H1: Pilates exercises will be more effective than walking exercises in improving muscle strength among women at risk of osteoporosis. H2: …

40 - 60 years of age Female Phase N/A
İ İrem CANLI

The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients

Osteoporosis is a progressive disease characterised by a decrease in bone mass, deterioration in bone microarchitecture, and increased fragility. Etiologically, it is divided into two types: primary (postmenopausal and senile) and secondary. Postmenopausal women are particularly at high risk; it is seen in more than 80% of women over the …

40 - 65 years of age All Phase N/A
S Sherief Abd-Elsalam, Ass. Prof.

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis

50 years of age All Phase 3

A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

This study is a multicenter, randomized, double-blinded, parallel-group Phase III clinical study to compare the clinical efficacy, safety, and immunogenicity of 9MW0311 and Prolia® in Chinese postmenopausal women with osteoporosis at high risk for fracture.

50 - 80 years of age Female Phase 3

Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

To investigate the efficacy and safety of eldecalcitol in postmenopausal women with low bone mineral density (BMD) or mild osteoporosis through a randomized, open-label, parallel controlled trial with calcitriol as the control.

50 years of age Female Phase 4
M Mary Jane De Souza, PhD

Prunes Preventing Bone Loss in Perimenopause

Dietary interventions of prune consumption during the transmenopausal period are innovative methods to prevent bone loss. Modern medicine does not intervene to prevent or attenuate this highly vulnerable period of bone loss which, if successfully attenuated, can potentially prevent/delay osteoporosis in women. The transmenopausal period represents an opportunistic window for …

44 - 55 years of age Female Phase N/A
F Fon-Yih Tsuang

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

This study is a prospective, randomized, controlled clinical trial comparing the efficacy of a 24-month cyclic therapy regimen (6 months of Romosozumab followed by 6 months of Denosumab, repeated for two years) versus a traditional sequential treatment regimen (12 months of Romosozumab followed by 12 months of Denosumab). The goal …

50 - 90 years of age Female Phase 4
A Alexandre BOUSSUGE, MD

Qualitative Study Exploring the Determinants Involved in the Management of Osteoporosis in Frail Elderly People

The aging population is associated with an increase in the number of elderly people as well as in chronic diseases, particularly osteoporosis and its fracture consequences, which lead to a decline in quality of life and life expectancy. Improved management of osteoporosis would help reduce the morbidity and mortality associated …

18 years of age All Phase N/A
A Aparna Patnaik, BA

Combined Anabolic Therapy

In this research study the study investigators want to learn more about the effect of two different FDA-approved medication regimens in the treatment of postmenopausal osteoporosis.

45 years of age Female Phase 4

Simplify language using AI